Cellectar Biosciences, Inc.CLRBNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank71
5Y CAGR+43.4%
Year-over-Year Change
Net other income and expenses outside core operations
5Y CAGR
+43.4%/yr
Long-term compound
Percentile
P71
Within normal range
vs 5Y Ago
6.1x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $1.19M | -83.6% |
| 2024 | $7.26M | +287.7% |
| 2023 | $-3.87M | -27.3% |
| 2022 | $-3.04M | -34175.4% |
| 2021 | $8918.00 | -95.5% |
| 2020 | $196177.00 | +128.9% |
| 2019 | $85712.00 | +105.4% |
| 2018 | $-1.58M | -4194.4% |
| 2017 | $38680.00 | -98.8% |
| 2016 | $3.27M | - |